Invention Grant
![6H-furo[2,3-E]indole compounds for the treatment of hepatitis C](/docs/US/2018-03-13/US09914739B2/abs.jpg.600x600.jpg)
- Patent Title: 6H-furo[2,3-E]indole compounds for the treatment of hepatitis C
-
Application No.: US15127054Application Date: 2015-03-20
-
Publication No.: US09914739B2Publication Date: 2018-03-13
- Inventor: Tao Wang , Zhongxing Zhang , John F. Kadow
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent James Epperson
- International Application: PCT/US2015/021641 WO 20150320
- International Announcement: WO2015/143257 WO 20150924
- Main IPC: C07D491/048
- IPC: C07D491/048 ; C07B59/00
![6H-furo[2,3-E]indole compounds for the treatment of hepatitis C](/abs-image/US/2018/03/13/US09914739B2/abs.jpg.150x150.jpg)
Abstract:
Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
Public/Granted literature
- US20170174696A1 6H-FURO[2,3-E]INDOLE COMPOUNDS FOR THE TREATMENT OF HEPATITIS C Public/Granted day:2017-06-22
Information query
